INTIBIO
0737.613.932 · rovalta.com · 25/09/2026
ACTIVE
INTIBIO
Financial year 2025 · Closed on 31/12/2025
Net result91 k €+84,3 %over 1 year
Gross margin278 k €+105,0 %over 1 year
Equity146 k €+165,6 %over 1 year
Overview
Identity
Source · BCE/KBOINTIBIO is a Private limited company incorporated in 2019. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Bree.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0737.613.932
- Incorporation
- 12/11/2019
- Legal form
- Private limited company
- Registered office
- Berkenbroekstraat 1
3960 Bree · FlandreSee on map - Contributed capital
- 3 000,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations10890Manufacture of other food products n.e.c.10890Manufacture of other food products n.e.c.72101Research and experimental development on natural sciences and engineering72109Research and experimental development on natural sciences and engineering+2
Joint committees (1)
- 20700
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 278 k € | +105% | 135,6 k € | +393% | 27,5 k € | -35.5% | 42,7 k € | +26.2% | 33,8 k € |
| EBITDA | 147,9 k € | +88.4% | 78,5 k € | +323% | 18,5 k € | -56.2% | 42,4 k € | +47.4% | 28,7 k € |
| Operating result | 127,6 k € | +81.3% | 70,4 k € | +369% | 15 k € | -61.3% | 38,8 k € | +54.0% | 25,2 k € |
| Net result | 91 k € | +84.3% | 49,4 k € | +386% | 10,2 k € | -65.1% | 29,1 k € | +22.2% | 23,8 k € |
| Balance sheet | |||||||||
| Equity | 146 k € | +166% | 55 k € | +886% | 5,6 k € | 0.0% | 5,6 k € | -88.0% | 46,5 k € |
| Total assets | 407,8 k € | +9.7% | 371,6 k € | +112% | 175,2 k € | +80.9% | 96,8 k € | +14.6% | 84,5 k € |
| Cash | 29,6 k € | +52.6% | 19,4 k € | -18.4% | 23,7 k € | -53.4% | 51 k € | +92.5% | 26,5 k € |
| Debts | 259,8 k € | -15.9% | 308,8 k € | +84.8% | 167,1 k € | +84.5% | 90,6 k € | +139% | 37,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
Berkenbroekstraat 1 3960 Bree| Company | CBE no. |
|---|---|
Berkenbroek● Active | 0416.261.642 |
MOCLERO● Active | 0453.881.509 |
VETERINARY INNOVATION ALLIANCE● Active | 0689.786.794 |
Via Nova Equine Services● Active | 0781.577.203 |
Virtus Bonarum Cellarum● Active | 0507.666.029 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 08/11/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 14 months |
| Filing date | 22/07/2026 | 31/07/2025 | 15/07/2024 | 08/06/2023 | 19/07/2022 | 14/07/2021 |
| General meeting | 25/06/2026 | 30/06/2025 | 16/06/2024 | 10/05/2023 | 30/06/2022 | 24/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 25/06/2026 | 22/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 31/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 16/06/2024 | 15/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 10/05/2023 | 08/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 30/06/2022 | 19/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 24/06/2021 | 14/07/2021 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/07/2025ONTSLAGEN - BENOEMINGEN
- Mandates13/05/2025ONTSLAGEN - BENOEMINGEN
- Mandates28/01/2025ONTSLAGEN - BENOEMINGEN - DIVERSEN
- Mandates19/07/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - DOEL - ONTSLAGEN - BENOEMINGEN
- Mandates22/08/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
- Mandates14/09/2020ONTSLAGEN - BENOEMINGEN
- Other14/11/2019RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202591 k €↑
- 2024Annual accounts 202449,4 k €↑
- 2024Name changeIntibio
- 2023Annual accounts 202310,2 k €↓
- 2023Name changeDBS Equestrian
- 2022Annual accounts 202229,1 k €↑
- 2021Annual accounts 202123,8 k €↓
- 2021Name changeVia Innova
- 2020Annual accounts 202039,6 k €
- 12/11/2019IncorporationPrivate limited company